Brain Blood Flow Responses at Rest and During Exercise

Sponsor
University of British Columbia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06142045
Collaborator
(none)
60
12

Study Details

Study Description

Brief Summary

Tight regulation of brain blood flow is integral for delivery of oxygen and energy for survival. During childhood, the brain has a twofold higher metabolic requirement, thus requires greater blood flow to match this. Despite this knowledge, brain blood flow responses and the mechanisms of regulation during maturation are largely unknown. Thus, we are trying to understand what happens to blood vessel function and the mechanisms of regulation at rest and during handgrip exercise. This will give us valuable information on brain blood vessel responses, which will help future interventions aimed at improving blood vessel function in youth, for future disease prevention. Utilizing the pubertal transition will provide insights into the influence of sex hormones on brain blood flow regulation.

The goal of this cross-sectional observational study is to examine the influence of age and maturation on cerebral blood flow regulation, achieved through exploring the responses to increases in carbon dioxide concentrations, and static handgrip exercise in children (7-10 years), adolescents (12-16 years) and young adults (19-35 years).

The main questions the study aims to answer are:
  • Investigate the brain blood flow responses to increases in carbon dioxide concentrations in children, adolescents and adults.

  • Investigate brain blood flow responses to handgrip exercise with and without increases in carbon dioxide concentrations in children, adolescents and adults.

During all protocols, participants will have their end-tidal gas concentrations measured and/or altered using prospective end-tidal gas targeting using a computer controlled gas blender system in which we have obtained Health Canada approval for.

Condition or Disease Intervention/Treatment Phase
  • Device: RespirACT RA-MR System

Detailed Description

The goal of this cross-sectional experimental study to determine the influence age, sex and pubertal status on cerebrovascular responses at rest and during isometric exercise.

The main objective is to investigate the regulatory mechanisms of cerebral blood flow during hypercapnia and isometric exercise, and determine whether any mechanistic differences in regulation are present with advancing age and maturation.

The following questions will be addressed in 20 healthy children (7-10 years), 20 healthy adolescents (12-16 years) and 20 young healthy adults (19-35 years), to compare the influence of age, sex and maturation on these responses, as follows:

  1. Investigate the brain blood flow responses to isometric exercise with and without hypercapnia (+9 mmHg carbon dioxide) in children, adolescents and adults.

  2. Investigate the brain blood flow responses to hypercapnia (+9 mmHg carbon dioxide) in children, adolescents and adults using a ramp incremental 4 minute protocol compared with a 30 second protocol, to identify which method is the most tolerable in children and adolescents.

  3. Determine whether sex, and the sex-dependent influences of age and maturation influence any of the brain blood flow responses to hypercapnia or isometric handgrip exercise.

To control and manipulate breathing gases during the study protocols, the partial pressures of end-tidal carbon dioxide and oxygen will be sampled at the mouth using the Investigational Testing Authorization approved computer controlled gas blender system. To target specific end-tidal carbon dioxide and oxygen levels during the clamped breathing and hypercapnic trials respectively, prospective end-tidal gas targeting will be utilized. The system allows for breath-by-breath regulation of end-tidal gases, independently of ventilation. End-tidal concentrations are prospectively targeted by controlling the inspired concentration of carbon dioxide and oxygen according to the previous expired breath, allowing this to be precisely controlled throughout the duration of the protocol. Gas analysis, and spirometry measures of tidal volume and breathing frequency will be recorded using the computer controlled system. Prospective end-tidal gas targeting is safe, with all inspired gases containing oxygen, with rigorous control procedures and fail-safe mechanisms which do not allow inhaled gases to fall outside of safe thresholds.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Cerebrovascular Responses to Isometric Exercise, and Hypercapnia in Children, Adolescents and Adults
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Children (7-10 years)

All groups of the experiment will be exposed to the same intervention. The intervention the participants are exposed to is the use of the computer controlled gas blender system for manipulation of end-tidal and arterial blood gases. This will be used for the following protocols, to either clamp end-tidal concentrations at resting levels or administer a hypercapnia challenge. The protocol includes assessment of cerebral blood flow responses (measured using ultrasound) to carbon dioxide; including a hypercapnia ramp protocol followed by a transient protocol. Following at least 30 minute wash out, participants will then perform isometric exercise at 30% of their maximal voluntary contraction for 2 minutes. Participants will perform the isometric handgrip exercise under 2 different conditions (hypercapnia (+9 mmHg) and clamped breathing; to maintain baseline end-tidal carbon dioxide and oxygen concentrations) with a 20-minute recovery period between each bout.

Device: RespirACT RA-MR System
RespirAct RA-MR™ is a computer-controlled gas blender to implement precise control of blood gases for a consistent and repeatable stimulus.

Adolescents (12-16 years)

All groups of the experiment will be exposed to the same intervention. The intervention the participants are exposed to is the use of the computer controlled gas blender system for manipulation of end-tidal and arterial blood gases. This will be used for the following protocols, to either clamp end-tidal at resting levels or administer a hypercapnia challenge. The protocol includes assessment of cerebral blood flow responses (measured using ultrasound) to carbon dioxide; including a hypercapnia ramp protocol followed by a transient protocol. Following at least 30 minute wash out, participants will then perform isometric exercise at 30% of their maximal voluntary contraction for 2 minutes. Participants will perform the isometric handgrip exercise under 2 different conditions (hypercapnia (+9 mmHg) and clamped breathing; to maintain baseline end-tidal carbon dioxide and oxygen concentrations) with a 20-minute recovery period between each bout.

Device: RespirACT RA-MR System
RespirAct RA-MR™ is a computer-controlled gas blender to implement precise control of blood gases for a consistent and repeatable stimulus.

Adults (18-35 years)

All groups of the experiment will be exposed to the same intervention. The intervention the participants are exposed to is the use of the computer controlled gas blender system for manipulation of end-tidal and arterial blood gases. This will be used for the following protocols, to either clamp end-tidal at resting levels or administer a hypercapnia challenge. The protocol includes assessment of cerebral blood flow responses (measured using ultrasound) to carbon dioxide; including a hypercapnia ramp protocol followed by a transient protocol. Following at least 30 minute wash out, participants will then perform isometric exercise at 30% of their maximal voluntary contraction for 2 minutes. Participants will perform the isometric handgrip exercise under 2 different conditions (hypercapnia (+9 mmHg) and clamped breathing; to maintain baseline end-tidal carbon dioxide and oxygen concentrations) with a 20-minute recovery period between each bout.

Device: RespirACT RA-MR System
RespirAct RA-MR™ is a computer-controlled gas blender to implement precise control of blood gases for a consistent and repeatable stimulus.

Outcome Measures

Primary Outcome Measures

  1. Cerebral blood flow [Experimental visit (1 day)]

    Ultrasound assessment of the internal carotid artery blood flow

Secondary Outcome Measures

  1. Cerebral blood velocity [Experimental visit (1 day)]

    Ultrasound assessment of the middle cerebral artery velocity

  2. Beat-by-beat blood pressure [Experimental visit (1 day)]

    Continuous assessment of mean arterial pressure responses

  3. Saliva hormone concentrations [Experimental visit (1 day)]

    Saliva specimen samples for the assessment of estrogen, progesterone, dehydroepiandrosterone and testosterone for the characterization of maturation status

  4. Physical activity questionnaire [Experimental visit (1 day)]

    Self report assessments of physical activity levels will be assessed using reliable and validated questionaries

  5. Anthropometrics [Experimental visit (1 day)]

    Body mass will be measured with electronic scales and stature standing and sitting height will be measured.

  6. Gas analysis [Experimental visit (1 day)]

    The partial pressures of end-tidal carbon dioxide and oxygen will be sampled at the mouth from a fitted respiratory face mask.

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Are aged between 7-10 years, 12-16 years or 19-35 years

  • Male or Female

  • Have a normal blood pressure (<160/110 mmHg) and are not taking any anti-hypertensive medications.

  • No prior or current history of cardiorespiratory of cerebrovascular diseases.

  • Can communicate in English

Exclusion Criteria:
  • Inability to perform handgrip exercise

  • Are currently taking any medications known to influence vascular function, heart rate or blood pressure

  • Have epilepsy

  • Are a current smoker

  • Have known cardiometabolic abnormalities

  • Have congenital cardiac abnormalities (e.g., tetralogy of Fallot)

  • Unstable angina (frequent chest pain)

  • Atrial Fibrillation

  • Myocardial infarction (heart attack) within the previous 3 months

  • Transient ischemic attack (TIA) within the previous 6 months

  • Heart failure ≥ class 2

  • Have a known respiratory disease (e.g., asthma)

  • Have a known metabolic disease (e.g., Type 1 diabetes)

  • Are unable to exercise

  • Are pregnant

  • Less than 6 months post childbirth or stopped breastfeeding within the last month

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of British Columbia

Investigators

  • Principal Investigator: Jared Baylis, MD, University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Ai McManus, Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT06142045
Other Study ID Numbers:
  • H23-02316
First Posted:
Nov 21, 2023
Last Update Posted:
Nov 21, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 21, 2023